Long-term (+52 weeks) randomized controlled trial of anti-depressants shows that they're safe and effective
One-OffHealth & Medicine3yManifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastYes 68.8%
Forecasters
7
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 3 hours ago
StaleMar 6, 25, 7:37 PM UTCMar 14, 30, 10:59 AM UTC
Trends
Rules
Randomized placebo-controlled studies of antidepressants are under 52 weeks, yet the median use of antidepressants is 5 years.
- This market predicts whether the next eligible trial of antidepressants shows that they are safe and effective over 52 weeks duration
- Definitions:
- eligible trial - placebo-controlled randomized controlled trial over 52 weeks that measures both efficacy and safety
- effective - beats placebo control
- safe - risks and side effects are not found to be worse than currently known
